美國居民不適用 XM 服務。

Universal Health Services beats second-quarter profit estimates on higher hospital admissions



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Universal Health Services beats second-quarter profit estimates on higher hospital admissions</title></head><body>

July 24 (Reuters) -Hospital operator Universal Health Services UHS.N beat Wall Street estimates for second-quarter profit on Wednesday, helped by higher patient admissions.

Shares of the company were up 6.2% at $197.50 after the bell.

The hospital operator also raised its annual adjusted profit forecast to $15.40 to $16.20 per share, compared to its previous estimate of $13 to $14 per share.

Hospital operators have been benefiting from an uptick in demand for medical care, especially from older adults - which was delayed during the pandemic.

The Pennsylvania-based company reported an adjusted profit of $4.31 per share for the three months ended June 30, compared with analysts' estimate of $3.28 per share, according to LSEG data.

Same facility adjusted admissions in the second quarter increased by 3.4% at acute care hospitals and fell by 0.4% at behavioral health care facilities.

The company's quarterly revenue rose 10.1% to $3.91 billion, beating analysts' estimate of $3.86 billion.

Larger peer HCA Healthcare HCA.N, the largest for-profit hospital operator in the United States, raised its annual profit forecast on Tuesday, expecting strong demand and volumes to continue through the remainder of the year.

Universal Health Services now expects 2024 revenue in the range on $15.57 billion to $15.75 billion; analysts on average were expecting $15.59 billion.



Reporting by Unnamalai L and Sneha S K in Bengaluru; Editing by Alan Barona

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明